Clin2
NCT07862114Possibly a fitNot yet recruiting

Testing drug interactions in healthy adults

Healthy ParticipantsGastrointestinal Neoplasms

Treatments studied

Part of Cancer, Digestive system clinical trials.

This study checks if stomach acid medicine and another drug affect how the body handles a new investigational drug. It helps researchers understand dosing for future patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
36 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You are in good overall health, with no major illnesses.
  • Your body mass index (BMI) is between 18 and 30.
  • You have no serious digestive, liver, or stomach conditions, and have not had stomach or weight-loss surgery.
  • You are not taking other medications that could interfere with the study drugs.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07700953Recruiting· Phase 1
How food and stomach medicine affect a new drug in healthy people

This trial tests how a new drug called ABSK-011 is absorbed by the body when taken with a low-fat meal, a high-fat meal, or a stomach acid medicine. Healthy volunteers are needed to help understand these effects.

Wuxi
NCT07867171Not yet recruiting· Phase 1
Effects of Velzatinib in people with kidney problems

This study looks at how a medicine called velzatinib affects people with moderate or severe kidney problems compared to those with normal kidney function. The goal is to see if the medicine is safe and how it is processed by the body.

NCT07859735Not yet recruiting· Phase 1
How liver function affects the drug velzatinib

This study tests how the body processes the drug velzatinib in people with different levels of liver function, compared to those with healthy livers. The results may help doctors determine the right dose for people with liver problems.

NCT07812077Not yet recruiting· Phase 1
Study of a new drug and how the body handles it

This trial tests a new medicine in healthy men to see how the body absorbs, breaks down, and removes it. This helps doctors understand how the drug works, which may lead to better treatments in the future.

NCT07800897Recruiting· Phase 1
How a new drug reacts with food and other medicines in healthy women

This trial checks how a new experimental drug (called Navlimetostat) interacts with other medicines and how food affects it. Healthy women participate to help researchers find the right dose and safety, which could later help people with cancer.

Québec, Quebec
NCT07629999Recruiting· Phase 1
Safety study of experimental drug BMS-986533 in healthy people

This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.

Lincoln, Nebraska

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.